Related Experiment Video
Updated: Jun 25, 2025
04:00
Author Spotlight: Assessing Surgical Frailty with Point-of-Care Ultrasound of Quadriceps Muscles
Published on: July 26, 2024
514
Frailty, Sarcopenia, Cachexia, and Malnutrition in Heart Failure
Daichi Maeda1, Yudai Fujimoto1, Taisuke Nakade1
1Department of Cardiovascular Biology and Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Korean Circulation Journal
|May 20, 2024
Summary
Heart failure patients often experience frailty, sarcopenia, cachexia, and malnutrition. Early recognition and integrated management strategies are crucial for improving outcomes in this aging population.
Area of Science:
- Gerontology and Cardiology
- Clinical Medicine
Background:
- Global aging increases heart failure prevalence.
- Heart failure is linked to frailty, sarcopenia, cachexia, and malnutrition, impacting prognosis.
- These conditions often coexist and share overlapping diagnostic criteria in heart failure patients.
Purpose of the Study:
- To review the epidemiology, diagnostics, overlap, and prognosis of frailty, sarcopenia, cachexia, and malnutrition in heart failure.
- To discuss the impact of these conditions on guideline-directed medical therapy effectiveness.
- To incorporate insights from the FRAGILE-HF study.
Main Methods:
- Literature review and analysis of existing data.
- Examination of diagnostic criteria and epidemiological trends.
- Synthesis of findings related to heart failure comorbidities.
Main Results:
- Frailty, sarcopenia, cachexia, and malnutrition are highly prevalent and interconnected in heart failure.
- These conditions can influence the efficacy of standard heart failure treatments.
- The FRAGILE-HF study provides key insights into these complex relationships.
Conclusions:
- Comprehensive understanding and management of these comorbidities are essential for heart failure patients.
- Early identification and integrated interventions may improve patient outcomes.
- Further large-scale randomized controlled trials are needed to optimize personalized treatment strategies.
Related Concept Videos
01:17Pathophysiology of Heart Failure
1.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.6K
01:26Imbalances in Cardiac Output
1.4K
The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
1.4K
01:26Heart Failure Drugs: Inotropic Agents
570
Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
570
01:19The Effect of Aging on Tissues
2.1K
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
2.1K
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
421
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
421
01:29Pathophysiology of Cardiac Performance
638
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
638